Status:

UNKNOWN

HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients

Lead Sponsor:

Assiut University

Conditions:

Interstitial Lung Disease

Eligibility:

All Genders

18-75 years

Brief Summary

To establish a simplified approach for assessment of severity of interstitial lung disease by evaluating the relationship between HRCT findings, the clinical severity score,spirometry and quality of l...

Detailed Description

The interstitial lung diseases are a group of parenchymal pulmonary disorders that affect the interstitium causing progressive fibrosis of lung tissue. These disorders characterized by dyspnea aggrava...

Eligibility Criteria

Inclusion

  • All patients admitted at Chest Department or presented to our out patient clinic with clinical diagnosis of Interstitial Lung Diseases among both sexes

Exclusion

  • patients under 18 years old.
  • pregnant patients.
  • patients with a history of previous lung resections.
  • presence of bronchial carcinoma or lobar consolidation.
  • patients contraindicated to perform pulmonary function will be excluded.

Key Trial Info

Start Date :

October 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05999838

Start Date

October 1 2023

End Date

February 1 2025

Last Update

August 21 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.